Mytocel MSK is a cutting-edge solution in regenerative medicine, offering minimally invasive treatments for joint restoration and pain relief. Utilizing Rigenera® technology, our approach creates autologous micrografts from a patient’s own tissue, providing long-lasting relief from conditions such as osteoarthritis, tendinitis, cartilage injuries, and chondromalacia patellae.
Our advanced technology combines biocompatible, tissue-specific biological components to restore joint health and improve mobility, offering the following benefits:
➤ Joint restoration
➤ Fast pain relief
➤ Long-lasting effects
➤ In just one session
➤ Minimally invasive procedure
➤ No need for repeated treatments
At Mytocel MSK, we are committed to advancing the field of orthopaedics and sports medicine, offering innovative, patient-centered solutions that are transforming the future of joint care.
Company Details
- Founded
- -
- Address
- Barcelona, Cataluña 08022, Es
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- HQ
- Barcelona, Cataluña
Mytocel Msk Questions
Mytocel Msk's website is https://www.instagram.com/mytocelmsk+
Mytocel Msk's LinkedIn profile is https://es.linkedin.com/company/mytocelmsk
Mytocel Msk's industry is
Medical Equipment Manufacturing
Mytocel Msk's top competitors are
Cd Pharma, S.a.,
Regenera Activa,
Bfi Medical Aesthetic Ventures,
Smith+nephew,
Clinipro,
Sumilab S.l.,
I2e3,
Otium Medical,
Rigenera - Hbw,
Meta Cell Technology.
Mytocel Msk's categories are Medical Equipment Manufacturing
Mytocel Msk's founding year is 2014
